There has been steady growth in the global nuclear imaging systems market, driven by heightened demand for advanced functional imaging in oncology, cardiology, and neurology. Unlike conventional imaging, nuclear methods such as PET and SPECT offer imaging of physiologic and metabolic processes, hence allowing earlier and more precise diagnosis. Individualized medicine and theranostics have gained popularity and are expected to continue increasing the pace of adoption in which nuclear imaging is used in planning and monitoring treatment. Further technological developments with hybrid systems such as PET/CT and SPECT/CT are providing better diagnostic accuracy and expanding clinical indications.
In line with the adoption rate, the global nuclear imaging systems market stood at US$ 3,653.86 million in 2024 and is expected to reach US$ 4,638.97 million by 2031. Moreover, novel radiotracers are being developed to widen their use in different disease areas. High cost, cumbersome procedures, and complex regulations, while posing a growth challenge, represent hidden opportunities across emerging nations where healthcare investments are steadily on the rise-aided by Al and digital workflows-greatly favoring the future growth of nuclear imaging technologies on a global scale.
You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00031639
Nuclear Imaging Systems Market Segmentation Analysis
Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.
- By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
- By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.
Nuclear Imaging Systems Market Drivers and Opportunities:
Rising Prevalence of Cancer
The increasing global burden of cancer is a major driver for the nuclear imaging systems market. Cancer diagnosis, staging, and monitoring need to have high-precision imaging that will identify abnormalities at earlier, usually asymptomatic stages. Nuclear imaging modalities like PET and SPECT are very capable of detecting metabolic and molecular activity, and hence they are indispensable aids in oncology. These modalities provide superior sensitivity over conventional anatomical imaging, particularly in the detection of metastases and in the evaluation of response to treatment.
For instance, according to the data published by the Global Cancer Observatory (GCO), ~19,976,499 new cancer cases were reported in 2022 across the globe. In addition, cancer resulted in 9,743,832 deaths globally in 2022.
With cancer incidence on the rise worldwide because of population aging, lifestyle, and environmental factors, demand for accurate and effective imaging devices increases accordingly. It compels the hospitals and diagnostic facilities to invest in sophisticated nuclear imaging systems, further driving market growth and innovation in the development of radiopharmaceuticals.
Rising Adoption in Personalized Medicine
As the adoption of personalized medicines increases the demand for nuclear imaging system is likely to increase. Personalized medicine involves individualized treatment strategies for patients based on their biological makeups, which necessitates accurate diagnostic imaging tools. Nuclear imaging, especially PET and SPECT, comes into prominence in this strategy by allowing disease activity to be visualized at the molecular level. It assists clinicians in selecting targeted therapies, tracking response to treatment, and making real- time plan adjustments, enhancing patient outcomes. Radiotracers employed in nuclear imaging are capable of detecting how a certain therapy is engaging with a patient’s body, so it is perfect for cancer treatment, cardiology, and neurological diseases. As healthcare systems become increasingly precision-based, incorporation of nuclear imaging into clinical practices becomes crucial, and hence there is more investment in equipment, software, and tracer development.
Nuclear Imaging Systems Market News and Key Development:
The nuclear imaging systems market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the nuclear imaging systems market are:
- On May 5, 2025, GE HealthCare, an American multinational medical technology company, announce that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of its impressive Aurora nuclear medicine system and Clarify DL. This advanced dual-head SPECT/CT is designed to enhance diagnostic capabilities and streamline workflows, offering clinicians excellent image quality and operational efficiency.
- On May 6, 2025, Lantheus Holdings, Inc., a radiopharmaceutical-focused company, announced a definitive agreement to sell its single photon emission computed tomography (SPECT) business to Illuminated Holdings, Inc., the parent company of SHINE Technologies, LLC.
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031639
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
